Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Clinical trial NCT04475432 · COMPLETED
Trial details
- NCT number
- NCT04475432
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2021-05-04
- Enrollment
- 421
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.